GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (OTCPK:KYKOF) » Definitions » EV-to-FCF

Kyowa Kirin Co (Kyowa Kirin Co) EV-to-FCF : 15.80 (As of May. 05, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Kyowa Kirin Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kyowa Kirin Co's Enterprise Value is $6,866 Mil. Kyowa Kirin Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was $435 Mil. Therefore, Kyowa Kirin Co's EV-to-FCF for today is 15.80.

The historical rank and industry rank for Kyowa Kirin Co's EV-to-FCF or its related term are showing as below:

KYKOF' s EV-to-FCF Range Over the Past 10 Years
Min: 14.1   Med: 34   Max: 345.2
Current: 17.21

During the past 13 years, the highest EV-to-FCF of Kyowa Kirin Co was 345.20. The lowest was 14.10. And the median was 34.00.

KYKOF's EV-to-FCF is ranked better than
61.1% of 509 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs KYKOF: 17.21

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Kyowa Kirin Co's stock price is $17.63. Kyowa Kirin Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.756. Therefore, Kyowa Kirin Co's PE Ratio for today is 23.32.


Kyowa Kirin Co EV-to-FCF Historical Data

The historical data trend for Kyowa Kirin Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co EV-to-FCF Chart

Kyowa Kirin Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.40 41.99 286.37 20.19 64.15

Kyowa Kirin Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.57 64.15 32.70 20.79 16.65

Competitive Comparison of Kyowa Kirin Co's EV-to-FCF

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's EV-to-FCF falls into.



Kyowa Kirin Co EV-to-FCF Calculation

Kyowa Kirin Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6866.141/434.59
=15.80

Kyowa Kirin Co's current Enterprise Value is $6,866 Mil.
Kyowa Kirin Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $435 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co  (OTCPK:KYKOF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kyowa Kirin Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.63/0.756
=23.32

Kyowa Kirin Co's share price for today is $17.63.
Kyowa Kirin Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.756.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Kyowa Kirin Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (Kyowa Kirin Co) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (Kyowa Kirin Co) Headlines

From GuruFocus